Expression and inducibility of CYP1A1, 1A2, 1B1 by β-naphthoflavone and CYP2B22, 3A22, 3A29, 3A46 by rifampicin in the respiratory and olfactory mucosa of pig

被引:31
作者
Messina, A. [1 ]
Nannelli, A. [1 ]
Fiorio, R. [1 ]
Longo, V. [2 ]
Gervasi, P. G. [1 ]
机构
[1] CNR, Area Ric, Ist Fisiol Clin, I-56100 Pisa, Italy
[2] CNR, Area Ric, Ist Biol & Biotecnol Agr, I-56100 Pisa, Italy
关键词
Rifampicin CYP induction; beta-Naphthoflavone CYP induction; Respiratory mucosa; Olfactory mucosa; Pig CYPS; XENOBIOTIC-METABOLIZING ENZYMES; RAT NASAL-MUCOSA; CONSTITUTIVE-ANDROSTANE RECEPTOR; HYDROCARBON HYDROXYLASE-ACTIVITY; P450-DEPENDENT MONOOXYGENASES; CYTOCHROME-P450; ENZYMES; GENE-EXPRESSION; CIGARETTE-SMOKE; AFLATOXIN B-1; LIVER;
D O I
10.1016/j.tox.2009.03.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The presence and inducibility of specific CYPs (1A1, 1A2, 1B1, 2B22, 3A22, 3A29 and 3A46) and the related transcriptional factors (AhR, CAR, PXR, and HNF4 alpha) were investigated, at activity and/or transcriptional level, in liver, respiratory and olfactory mucosa of control and P-naphthoflavone (beta NF)-treated pigs an agonist of AhR, or rifampicin (RIF), an agonist of PXR. Experiments with real-time PCR showed that CYP1A1 mRNA was enhanced by ONE although at different extent, in liver, respiratory and olfactory tissues, whereas mRNAs of CYP1A2 and 1B1 were increased only in liver. Accordingly, in microsomes of both nasal tissues, the transcriptional activation of CYP1A1 was accompanied by an induction of ethoxyresorufin deethylase activity (a marker of this isoform) but not of methoxyresorufin demethylase activity (a marker of CYP1A2). The rifampicin treatment resulted in a transcriptional activation of CYP2B22 and CYP3As genes in liver but not in respiratory and olfactory mucosa. In parallel, the marker activity of CYP2B (ethoxy 4-(trifluoromethyl)coumarin deethylase) and CYP3As (6 beta-testosterone hydroxylase and benzyloxyquinoline debenzylase) were induced in liver microsomes but not in the nasal ones. Considering the transcriptional factors, the basal expression of AhR mRNA was found to be as high in liver as in both nasal tissues but not susceptible to induction by ONE Also PXR mRNA was found, aside liver, well expressed in the nasal tissues, whereas CAR and HNF4 alpha mRNAs were barely detected. In any case, these transcripts appeared to be enhanced by RIF treatment. Our results demonstrated that in the respiratory and olfactory mucosa of pig, although the presence of AhR, only CYP1A1, but not 1A2 and 1B1 resulted to be inducible by beta NF. Similarly, it was observed that in these nasal tissues, although the presence of PXR, neither CYP2B22 nor any CYP3A resulted to be inducible by RIF. Thus, the regulation mechanism of CYP1A2, 1B1, 2B22, 3A22, 3A29, and 3A46, in the nasal mucosa involves tissue-enriched transcriptional factors others than AhR, CAR, PXR, and HNF4 alpha, which are fundamental in liver. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:47 / 52
页数:6
相关论文
共 50 条
  • [21] Effect of Polyunsaturated Fatty Acids ω-3 on the Induction of Activity and Expression of CYP1A1 and CYP1A2 Genes in the Liver of Rats under the Influence of Indole-3-Carbinol
    Kravchenko, L. V.
    Tutel'yan, V. A.
    Trusov, N. V.
    Guseva, G. V.
    Aksenov, I. V.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2014, 156 (03) : 327 - 331
  • [22] Expression of CYP2C49, CYP7A1, CYP2B22, ACSL5 and APOA4 genes in the liver of Pietrain and Landrace pigs.
    Oczkowicz, M.
    Ropka-Molik, K.
    Wojtaszek, M.
    Warzecha, J.
    JOURNAL OF ANIMAL SCIENCE, 2016, 94 : 137 - 138
  • [23] Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin
    Walker, NJ
    Portier, CJ
    Lax, SF
    Crofts, FG
    Li, Y
    Lucier, GW
    Sutter, TR
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1999, 154 (03) : 279 - 286
  • [24] Expression of organic anion-transporting polypeptides 1B3, 1B1, and 1A2 in human pancreatic cancer reveals a new class of potential therapeutic targets
    Kounnis, Valentinos
    Ioachim, Elli
    Svoboda, Martin
    Tzakos, Andreas
    Sainis, Ioannis
    Thalhammer, Theresia
    Steiner, Georg
    Briasoulis, Evangelos
    ONCOTARGETS AND THERAPY, 2011, 4 : 27 - 32
  • [25] Effects of Baicalin on Pharmacokinetics of Florfenicol and mRNA Expression of CYP1A2, CYP2C11, CYP3A1, UGT1A1, MDR1, and ABCC2 in Rats
    Li, Si-Cong
    Li, Xu-Ting
    Wang, Bin
    Yang, Rui
    Zhang, Min
    Li, Jin-Liang
    Huang, Wei
    Cao, Liang
    Xiao, Song-Yang
    PHARMACOGNOSY MAGAZINE, 2020, 16 (67) : 1 - 6
  • [26] Enzymatic characterization of in vitro-expressed Baikal seal cytochrome P450 (CYP) 1A1, 1A2, and 1B1: Implication of low metabolic potential of CYP1A2 uniquely evolved in aquatic mammals
    Iwata, Hisato
    Yamaguchi, Keisuke
    Takeshita, Yoko
    Kubota, Akira
    Hirakawa, Shusaku
    Isobe, Tomohiko
    Hirano, Masashi
    Kim, Eun-Young
    AQUATIC TOXICOLOGY, 2015, 162 : 138 - 151
  • [27] A high-throughput cell-based gaussia luciferase reporter assay for measurement of CYP1A1, CYP2B6, and CYP3A4 induction
    Li, Han
    Wang, Yu-Guang
    Ma, Zeng-Chun
    Yun-Hang, Gao
    Ling, Song
    Teng-Fei, Chen
    Guang-Ping, Zhang
    Gao, Yue
    XENOBIOTICA, 2021, 51 (07) : 752 - 763
  • [28] Disruption of the Gene for CYP1A2, which Is Expressed Primarily in Liver, Leads to Differential Regulation of Hepatic and Pulmonary Mouse CYP1A1 Expression and Augmented Human CYP1A1 Transcriptional Activation in Response to 3-Methylcholanthrene In Vivo
    Jiang, Weiwu
    Wang, Lihua
    Kondraganti, Sudha R.
    Fazili, Inayat S.
    Couroucli, Xanthi I.
    Felix, Edward A.
    Moorthy, Bhagavatula
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 335 (02) : 369 - 379
  • [29] Alteration in the Expression of Cytochrome P450s (CYP1A1, CYP2E1, and CYP3A11) in the Liver of Mouse Induced by Microcystin-LR
    Zhang, Bangjun
    Liu, Yang
    Li, Xiaoyu
    TOXINS, 2015, 7 (04): : 1102 - 1115
  • [30] The fluorescence-based competitive counterflow assay developed for organic anion transporting polypeptides 1A2, 1B1, 1B3 and 2B1 identifies pentamidine as a selective OATP1A2 substrate
    Ungvari, Orsolya
    Bakos, Eva
    Kovacsics, Daniella
    Ozvegy-Laczka, Csilla
    FASEB JOURNAL, 2023, 37 (11)